Pharmacological Inhibition of Poly(ADP-ribose) Polymerase in Cardiovascular Disorders: Future Directions

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|3|3|301-303

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.3, Iss.3, 2005-07, pp. : 301-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Poly(ADP-ribose) polymerase and aging - A critical analysis

By Burkle A.  

Experimental Gerontology, Vol. 33, Iss. 6, 1998-09 ,pp. : 519-523

Elsevier

Access to resources Recommend Favorite

Role of Nitrosative Stress and Activation of Poly(ADP-ribose) Polymerase-1 in Cardiovascular Failure Associated with Septic and Hemorrhagic Shock

By  

Current Vascular Pharmacology, Vol. 3, Iss. 3, 2005-01 ,pp. : 293-299

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP-ribose) polymerase-1, DNA repair and mammalian longevity

By Burkle A.   Beneke S.   Brabeck C.   Leake A.   Meyer R.   Muiras M.-L.   Pfeiffer R.  

Experimental Gerontology, Vol. 37, Iss. 10, 2002-10 ,pp. : 1203-1205

Elsevier

Access to resources Recommend Favorite

Role for Poly(ADP-ribose) Polymerase Activation in Diabetic Nephropathy, Neuropathy and Retinopathy

By  

Current Vascular Pharmacology, Vol. 3, Iss. 3, 2005-07 ,pp. : 267-283

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Role of Oxidative-Nitrostative Stress and Poly(ADP-ribose) Polymerase in Cardiovascular Pathophysiology (Guest Editor: Pal Pacher)]

By  

Current Vascular Pharmacology, Vol. 3, Iss. 3, 2005-01 ,pp. : 207-207

Bentham Science Publishers

Access to resources Recommend Favorite